A lack of consensus guidelines or a belief that current evidence does not support such guidelines might be justified if a clinician expresses a commitment to patient-centered care and shared decision making.

Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?

Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility.

Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity.

Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness.

When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence?

Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects.

The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes.

Dr. Oz’s advice has raised ethical questions about medicine as a profession, its evidentiary standards, and its role in maintaining public trust.

Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions.